Related Experiment Video
Updated: Apr 16, 2026
06:15
Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
1.5K
Evolving practice: X-linked agammaglobulinemia and lung transplantation
S Barnes1, S Kotecha, J A Douglass
1General Medical Department, Southern Health, Melbourne, Australia.
Summary
Lung transplantation in X-linked agammaglobulinemia (XLA) patients with bronchiectasis shows promising short-term results but disappointing long-term outcomes due to high rates of pulmonary sepsis and chronic lung allograft dysfunction.
Area of Science:
- Immunology
- Pulmonology
- Transplantation
Background:
- X-linked agammaglobulinemia (XLA) is a primary immunodeficiency leading to recurrent infections and bronchiectasis.
- Lung transplantation is a potential but understudied option for end-stage lung disease in XLA patients.
Observation:
- This study reports on six XLA patients who underwent lung transplantation.
- Patients presented with severe bronchiectasis secondary to XLA.
Findings:
- Short-term outcomes post-lung transplantation in XLA patients were excellent.
- Long-term outcomes were poor, with a high incidence of pulmonary sepsis and chronic lung allograft dysfunction (CLAD).
Implications:
- Lung transplantation offers temporary benefit for XLA patients with end-stage lung disease.
- Further research is needed to improve long-term survival and manage complications like sepsis and CLAD in this population.
